Association of p27Kip1, Cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 3991-3998

  Dellas, Athanassios ^a   Schultheiss, Elisabeth ^a   Leivas, Maria R ^a   Moch, Holger ^a   Torhorst, Joachim ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cell cycle; Cervical carcinoma; Cyclin; Immunohistochemistry

Indexed keywords

CYCLIN E; DNA; MYC PROTEIN; PROTEIN P27;

ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA HYBRIDIZATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; WART VIRUS;

CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE PROGRESSION; FEEDBACK; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MICROTUBULE-ASSOCIATED PROTEINS; MITOTIC INDEX; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 0032438868     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22, 1994.
2. Godwin AK, Hamilton TC and Knudson AG, Jr.: Oncogenes and Antioncogenes. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology. Philadelphia, J. B. Lippincott Company, 1992, pp 87-116.
3. Bai MK, Costopoulos JS, Christoforidou BP and Papadimitriou CS: Immunhistochemical Deletion of the c-myc Oncogene Product in Normal, Hyperplastic and Carcinomatous Endometrium. Oncology 51: 314-319, 1994.
4. Kelly K and Sibenlist U: The regulation and expression of c-myc in normal and malignant cells. Ann Rev Immunol 4: 317-338, 1986.
5. Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G and Eilers M: Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA 90: 3685-3689, 1993.
6. Kip1 is abrogated by c-Myc. EMBO J 15: 6595-6604, 1996.
7. Dellas A, Schultheiss E, Holzgreve W, Oberholzer M, Torhorst J and Gudat F: Investigation of the Bcl-2 and C-myc expression in relationship to the Ki-67 labelling index in cervical intraepithelial neoplasia. Int J Gynecol Pathol 16: 212-218, 1997.
8. Riou G, Barrois M, Le MG, George M, Le Doussal V and Haie C: C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet 1: 761-763, 1987.
9. Riou GF, Bourhis J and Le MG: The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer. Anticancer Res 70: 1225-1231, 1990.
10. Sowani A, Ong G, Dische S, Quinn C, White J, Soutter P, Waxman J and Sikora K: c-myc oncogene expression and clinical outcome in carcinoma of the cervix. Mol Cell Probes 3: 117-123, 1989.
11. Bourhis J, Le MG, Barrois M, Gerbaulet A, Jeannel D, Duvillard P, Le Doussal V, Chassagne D and Riou G: Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix. J Clin Oncol 8: 1789-1796, 1990.
12. Durst M, Croce CM, Gissmann L, Schwarz E and Huebner K: Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci U S A 84: 1070-1074, 1987.
13. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilcyznski S and et al.: Molecular analysis of the cyclin-dependent kinase inhibitor gene p27Kip1 in human malignancies. Cancer Res 5585: 2266-2269, 1995.
14. Kip1 in multistage colorectal carcinogenesis. Cancer Res 58: 114-122, 1998.
15. Kip1. Cancer Res 56: 1389-1399, 1996.
16. Kip1 expression. Cell Growth Differ 8: 393-405, 1997.
17. Kip1 protein: prognostic implications in primary breast cancer. Nat Med 3: 227-230, 1997.
18. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3: 222-225, 1997.
19. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM and Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3: 231-234, 1997.